Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04469530
Title Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors (AflacST1903)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

sarcoma

Advanced Solid Tumor

Ewing sarcoma

rhabdomyosarcoma

osteosarcoma

rhabdoid cancer

Therapies

Celecoxib + Cyclophosphamide + Etoposide + Sirolimus

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.